Docetaxel-induced hand and foot syndrome in a patient with metastatic breast carcinoma
Hand and foot syndrome (HFS) is a well-known complication of chemotherapeutic drugs given in a dose-dense manner. Our patient was a 52-year-old female with metastatic breast carcinoma on salvage chemotherapy regimen with docetaxel at a dose of 60 mg/m 2 . The patient had grade 3 HFS characterized by...
Main Authors: | Ravichandran Gurumurthi, Ramesh BV Nimmagadda, Subhashini Mohan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: | |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2013;volume=58;issue=5;spage=380;epage=382;aulast=Gurumurthi |
Similar Items
-
Palmar-Plantar Erythrodysesthesia Associated with Chemotherapy and Its Treatment
by: Katherina Podlekareva Farr, et al.
Published: (2011-04-01) -
Sorafenib and sunitinib: A dermatologist′s perspective
by: Vijendran Pragasam, et al.
Published: (2014-01-01) -
Anticancer Drug Induced Palmar Plantar Erythrodysesthesia
by: Muthiah Palaniappan, et al.
Published: (2014-10-01) -
Clinical evaluation of the effectiveness of treatment of the hand-foot syndrome – skin toxicity of antitumor target therapy with multi-kinase inhibitors
by: Evgeniya A. Shatokhina, et al.
Published: (2018-12-01) -
Extracorporeal Elimination of Circulating Pegylated Liposomal Doxorubicin (PLD) to Enhance the Benefit of Cytostatic Therapy in Platinum-Resistant Ovarian Cancer Patients
by: Ondřej Kubeček, et al.
Published: (2015-07-01)